Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Equity and diversity in academic medicine: a perspective from the JCI editors.

Resar LM, Jaffee EM, Armanios M, Jackson S, Azad NS, Horton MR, Kaplan MJ, Laiho M, Maus MV, Sumner CJ, Wheelan SJ, Wills-Karp M.

J Clin Invest. 2019 Oct 1;129(10):3974-3977. doi: 10.1172/JCI130902. No abstract available.

2.

Targeting the mTOR pathway in idiopathic multicentric Castleman disease.

Stern RM, Berliner N.

J Clin Invest. 2019 Oct 1;129(10):4086-4088. doi: 10.1172/JCI131332.

3.

Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome.

Fakih M, Ouyang C, Wang C, Tu TY, Gozo MC, Cho M, Sy M, Longmate JA, Lee PP.

J Clin Invest. 2019 Oct 1;129(10):4464-4476. doi: 10.1172/JCI127046.

4.

Revealing the molecular signaling pathways of mucus stasis in cystic fibrosis.

Birket SE, Rowe SM.

J Clin Invest. 2019 Oct 1;129(10):4089-4090. doi: 10.1172/JCI131652.

5.

IL-1β dominates the promucin secretory cytokine profile in cystic fibrosis.

Chen G, Sun L, Kato T, Okuda K, Martino MB, Abzhanova A, Lin JM, Gilmore RC, Batson BD, O'Neal YK, Volmer AS, Dang H, Deng Y, Randell SH, Button B, Livraghi-Butrico A, Kesimer M, Ribeiro CM, O'Neal WK, Boucher RC.

J Clin Invest. 2019 Oct 1;129(10):4433-4450. doi: 10.1172/JCI125669.

6.

Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases.

Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A, Polgreen PM, Narayanan NS, Yuan Y, Chen Z, Su W, Han Y, Zhao C, Gao L, Ji X, Welsh MJ, Liu L.

J Clin Invest. 2019 Oct 1;129(10):4539-4549. doi: 10.1172/JCI129987.

7.

Metabolically healthy obesity: facts and fantasies.

Smith GI, Mittendorfer B, Klein S.

J Clin Invest. 2019 Oct 1;129(10):3978-3989. doi: 10.1172/JCI129186. Review.

Supplemental Content

Loading ...
Support Center